GVK Biosciences

This week, GVK Biosciences said that the US Food and Drug Administration has licensed GOSTAR, a manually curated database of structure-activity relationship, pharmacokinetic, and toxicity data.

The University of Dundee's drug discovery unit has licensed GVK Biosciences' Online SAR Database , or GOSTAR, a manually curated database that contains over 6 million manually curated compounds and more than 18 million quantitative SAR points.

GVK Biosciences said this week that it has tapped Genesis Genetics Asia to distribute its informatics database products and services to pharmaceutical and biotechnology companies in Taiwan.

NEW YORK (GenomeWeb News) – Indian contract research organization GVK Biosciences today announced a distribution deal with Genesis Genetics Asia covering Taiwan.

NEW YORK (GenomeWeb News) – Indian contract research organization GVK Bio announced today the extension of its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration.

GVK Biosciences said this week that the US Food and Drug Administration has renewed its license to the Hyderabad, India-based firm's clinical biomarker database.

NEW YORK (GenomeWeb News) – Indian contract research organization GVK Biosciences today announced the licensing of its clinical biomarker database to the National Institutes of Health's National Cancer Institute.

GVK Biosciences said this week that Japanese pharmaceutical company Astellas has renewed its license to the GVK Bio Structure Activity Relationship database, known as GOSTAR.

Pages

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.